Independent Research Presented at Pediatric Endocrine Society Annual Meeting

News | May 1, 2022

BioMarin Editorial Team

BioMarin congratulates Dr. Andrew Dauber, Chief of Endocrinology at Children’s National Hospital in Washington, D.C., who has recently presented independent research to study a BioMarin therapy, in selected genetic causes of short stature. Dr. Dauber presented preliminary findings at the Pediatric Endocrine Society (PES) Annual Meeting on Sunday, May 1. For more information on Dr. Dauber’s research, please click here.

More from BioMarin

Our Motivation

Caring for Children with Achondroplasia: An Interview with Dr. Ciara McDonnell

Dr. McDonnell, a renowned pediatric endocrinologist, shares her perspective about the current care experience for families affected by achondroplasia, how care has evolved and what makes her optimistic about the future.

Science

Targeting the Underlying Genetic Causes of Heart Disease

BioMarin researchers are leveraging the company’s expertise in translating genetic discoveries into potentially transformative medicines to address the root causes of certain forms of cardiovascular disease.

Our Motivation

RARE Scholars Program Provides Support to College Students Living with Genetic Conditions

The program was created to support U.S. college students living with one of four rare genetic conditions who have demonstrated exceptional leadership and engagement in school and community activities.